Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey

New Microbiologica

Volumn 32, Issue 2, 2009, Pages 153-158

  Yüksel, Pelin ^a   Tansel, Özlem ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Drug resistance; Mycobacterium tuberculosis; PncA mutations; Pyrazinamide

Indexed keywords

AMIDASE; BACTERIAL DNA; PNCA PROTEIN, MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; DNA SEQUENCE; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TURKEY (REPUBLIC);

AMIDOHYDROLASES; AMINO ACID SUBSTITUTION; ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, PULMONARY; TURKEY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 67649935699     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BARCO P., CARDOSO R.F., HIRATA R.D.C., LEITE C.Q.F., PANDOLFI J.R., SATO D.N., SHIKAMA M.L., FIUZA DE MELO F, MAMIZUKA E.M., CAMPANERUT P.A.Z., HIRATA M.H. (2006). pncA mutations in pyrazinamide-re- sistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J. Antimicrob. Chemother. 58, 930-935.
2. BROWN T.J., TANSEL Ö., FRENCH G.L. (2000). Simultaneous identification and typing of multi drug- resistant Mycobacterium tuberculosis isolates by analysis of pnc A and rpo B. J. Med. Microbiol. 49, 651-656.
3. DAVIES A.P., BILLINGTON O.J., MCHUGH T.D., MITCHISON D.A., JARLIER V. (2000). Comparison of phenotypic and genotypic methods for pyrazinamide suscep- tibility testing with Mycobacterium tuberculosis. J. Clin. Microbiol. 38, 3686-3688.
4. DENKIN S.,VOLOKHOV D., CHIZHIKOV V, ZHANG Y. (2005). Microarray-based pncA genotyping of pyrazi- namide-resistant strains of Mycobacterium tuberculosis. J. Med. Microbiol. 54, 1127-1131.
5. HIRANO K., TAKAHASHI Y, KAZUMI Y, FOKASAWA Y, ABE C. (1998). Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle and Lung Dis. 78 (2), 117-122.
6. HUANGT.S., lEES.S., TUH.Z., HUANG W.K., CHEN Y.S., HUANG C.K., WANN S.R., LIN H.H., LIU Y.C (2003). Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan. Antimicrob. Agents Chemother. 47 (11), 3672-3673.
7. LEE K.W., LEE J.M., JUNG K.S. (2001). Characterizations of pnc A mutations of pyrazinamide- resistant Mycobacterium tuberculosis in Korea. J. Korean Med. Sea. 16 (5), 537-543.
8. LEMAITRE N., SOUGAKOFF W., TRUFFOT- PERNOT C, JARLIER V. (1999). Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA. Antimicrob. Agents Chemother. 43 (7), 1761-1763.
9. MCCAMMON M.T., GILLETTE J.S., THOMAS D.P., RAMASWAMY S.V., ROSAS I.I., GRAVISS E.A., VIJG J., QUITUGUA T.N. (2005). Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region. Antimicrob. Agents Chemother. 49 (6), 2210-2217.
10. MESTDAGH M., FONTEYNE P.A., REALINI L., ROSSAU R., JANNES G., MIJS W., DE SMET K.A., PORTAELS F, VAN E., EECKHOUT E. (1999). Relationship between pyrazinamide resistance loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug- resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 9, 2317- 2319.
11. MILLER M. A., THIBERT E, DESJARDINS S., SIDDIQI S.H., DASCAL A. (1995). Testing of susceptibility to pyraz- inammide: comparison of BACTEC method with pyrazinamidase assay. J. Clin. Microbiol. 33, 2468- 2470.
12. MORLOCK G.P., CRAWFORD J.T., BUTLER W.R., BRIM S.E., SIKES D., MAZUREK G.H., WOODLEY C.L., COOKSEY R.C. (2000). Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44 (9), 2291-2295.
13. O'SULLIVAN D.M., MCHUGH T.D., GILLESPIE S.H. (2005). Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution. .J.Antimicrob. Chemother. 55, 674-679.
14. PARK S.K., LEE J.Y., CHANG C.L., LEE M.K., SON H.C., KIM CM., JANG H.J., PARK H.K., JEONG S.H. (2001). PncA mutations in clinical Mycobacterium tuberculosis isolates from Korea. BMC lnfeet. Dis. 1, 4.
15. PFYFFER G.E., BONATO D.A., EBRAHIMZADEH A., GROSS W., HOTALING J., KORNBLUM J., LASZLO A., ROBERTS G., SALFINGER M., WITTWER E, SIDDIQI S. (1999). Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J. Clin. Microbiol. 37 (10), 3179-3186.
16. PORTUGAL I., BARREIRO L., MONIZ-P EREIRA J., BRUM L. (2004). PncA mutations in pyrazinamide- resistant Mycobacterium tuberculosis isolates in Portugal. Antimicrob. Agents Chemother. 48 (7), 2736-2738.
17. RODRIGUES V.F.S., TELLES M.A., RIBEIRO M.O., CAFRUNE P.I., ROSSETTI M.L.R., ZAHA A. (2005). Characterization of pncA mutations in pyrazi- namide-resistant Mycobacterium tuberculosis in Brazil. Antimicrob. Agents Chemother. 49 (1), 444- 446.
18. SCORPIO A., ZHANG Y. (1996). Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazi- namide in tubercle bacillus. Nat. Med. 2, 662-667.
19. SEKIGUCHI J., MIYOSHI-AKIYAMA T., AUGUSTYNOWICZ- KOPEC E., ZWOLSKA Z., KIRIKAE F., TOYOTA E., KOBAYASHI I., MORITA K., KUDO K., KATO S., KURATSUJI T, MORI T, KIRIKAE T. (2007). Detection of multidrug resistance in Mycobacterium tuberculosis.J. Clin. Microbiol. 45 (1), 179-192.
20. SUZUKI Y, SUZUKI A., TAMAURU A., KATSUKAWA C, ODA H. (2002). Rapid detection of pyrazinamide-resist- ant Mycobacterium tuberculosis by a PCR-based in vitro system. J. Clin. Microbiol. 40 (2), 501-507.
21. TRACEVSKA T., NODIEVA A., SKENDERS G. (2004). Spectrum of pncA mutations in multidrug-resist- ant Mycobacterium tuberculosis isolates obtained in Lativia. Antimicrob. Agents Chemother. 48 (8), 3209-3210.
22. WAYNE L.G. (1974). Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109, 147-151.
23. WORLD HEALTH ORGANIZATION. (2006). Extensively drug- resistant tuberculosis (XDRTB): recommendations for prevention and control. Wkly. Epidemiol. Rec. 81, 430-432.